A Study to Assess Efficacy and Safety Intravenous Benapenem in Patients With Complicated Urinary Tract Infection (cUTI) or Acute Pyelonephritis (AP)

NCT04505683 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

112

Enrollment

INDUSTRY

Sponsor class

Conditions

Complicated Urinary Tract Infection Including Acute Pyelonephritis

Interventions

DRUG: Benapenem
DRUG: Ertapenem

Sponsor

Sihuan Pharmaceutical Holdings Group Ltd.